 |
|
|
2009 Neuroendocrine Tumor Symposium
Diagnosis & Management Strategies:
A Multidisciplinary Approach
|
|
Overview of the Event
|
|
On October 2 & 3, 2009, NANETS second annual continuing medical education program "Diagnosis & Management
Strategies: A Multidisciplinary Approach" was jointly sponsored with The University of Texas M. D. Anderson
Cancer Center. This symposium was held in Charlotte, North Carolina and received an enthusiastic response
by both attendees and faculty.
The conference began with a two and a half hour overview of the proposed NANETS consensus guidelines.
These presentations sparked some lively discussion and input from participants. The remainder of the
symposium was packed with the most current treatment information and cutting-edge scientific and educational
developments in neuroendocrine tumor diseases. The quality of data presented by outstanding faculty
highlighted the impact that our recently formed society is having on neuroendocrine tumor (NET) research,
education and patient care.
With over 175 specialists from around the world participating in the symposium, the message was clear how vital
it is to use a multidisciplinary team approach to understand, diagnose and treat NETs.
Attendees from multiple
specialties including medical and surgical oncologists, endocrinologists, interventional radiologists, nurse
practitioners and gastroenterologists, shared information and dialogue to advance the care of NET patients.
Comprehensive efforts are underway to maximize collaborative opportunities and to train the "NET" generation of
health care providers and researchers. Being the first organization in North America to provide a comprehensive
continuing medical education (CME) program on NETs, NANETS plans to enhance our training by developing more
educational forums and tools for NET disease management.
Below you will find a list of recordings produced during the event. Please share this information with your colleagues
to help disseminate this important information. In addition, abstracts
of the poster sessions are available for review. The number and quality of submissions this year are quite impressive.
|
|
NANETS Guidelines Session I (Day 1 morning)
|
|
|
|
NANETS Guidelines Session II (Day 1 morning)
|
|
|
|
Chairman's Address (Day 1 afternoon)
|
|
|
|
Educational Session I: Classification, Staging & Prognostic Factors for Neuroendocrine Tumors (Day 1 afternoon)
|
|
|
|
Educational Session II: Surgery & Hepatic Directed Therapy (Day 1 afternoon)
|
|
|
|
Summary Session Day I (Day 1 afternoon)
|
|
|
|
Oral Abstract Session: Clinical Research (Day 2 morning)
|
|
- Daily Oral Everolimus Activity
in Patients with Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic
Chemotherapy: A Phase II Trial
Presenter(s): James C. Yao
View:
broadband |
narrowband |
MP3 (audio)
- Where Do We Go Next?
Presenter(s): Kjell E. Oberg
View:
broadband |
narrowband |
MP3 (audio)
|
Educational Session III: Peptide Receptor Radionuclide Therapy - PRRT (Day 2 morning)
|
|
|
|
Educational Session IV: Role of New Somatostatin Analogs:
Symptom Control or Disease Stabilization? (Day 2 morning)
|
|
|
|
Educational Session V: Overview of Systemic Therapies (Day 2 afternoon)
|
|
|
|
Oral Abstract Session: Basic Research (Day 2 afternoon)
|
|
- Identification of a Novel Raf-1
Activating Drug That Inhibits Gastrointestinal Carcinoid Growth
Presenter(s): Mackenzie Cook
View:
broadband |
narrowband |
MP3 (audio)
- A Large-scale SNP Evaluation
Reveals an Association of a TSC2 SNP with Sporadic Neuroendocrine Tumor Risk
Presenter(s): Monica Ter-Minassian
View:
broadband |
narrowband |
MP3 (audio)
- Distinct mTOR Pathway
Activity in Neuroendocrine Tumors of the Pancreas and Small Intestine Revealed by
Immunohistochemical Analysis
Presenter(s): Eric Nakakura, Herbert Chen
View:
broadband |
narrowband |
MP3 (audio)
|
Summary Session (Day 2 afternoon)
|
|
|
|
Closing Keynote Address (Day 2 afternoon)
|
|
|
|
|
compatability check
|
get technical help
